U.S. FDA approves Daiichi Sankyo’s treatment for rare joint tumor
(Reuters) – The U.S. Food and Drug Administration on Friday approved Daiichi Sankyo Co Ltd’s treatment for adult patients with…
FDA declines to approve Daiichi Sankyo’s blood cancer treatment
(Reuters) – Japan’s Daiichi Sankyo Co said on Friday the U.S. Food and Drug Administration has declined to approve its…